1579-P: Prevalence and Incidence of Obesity and Diabetes in the United States, 2011-2017

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1579-P
Author(s):  
JANNIE NIELSEN ◽  
ED GREGG ◽  
K.M. VENKAT NARAYAN ◽  
SOLVEIG A. CUNNINGHAM
2015 ◽  
Vol 12 ◽  
Author(s):  
Nicholas Freudenberg ◽  
Emily Franzosa ◽  
Nancy Sohler ◽  
Rui Li ◽  
Heather Devlin ◽  
...  

2016 ◽  
Vol 36 (suppl_1) ◽  
Author(s):  
Hadii M Mamudu ◽  
Timir Paul ◽  
Liang Wang ◽  
Sreenivas P Veeranki ◽  
Hemang B Panchal ◽  
...  

Background: Hypertension (HTN) is one of the major risk factors for cardiovascular diseases (CVD) that afflicts one-third of the population in United States (US). This study examined the association between multiple modifiable risk factors for HTN in a rural hard-to-reach population. Methods: During January 2011 and December 2012, 1629 community-dwelling asymptomatic individuals from central Appalachia participated in screening for subclinical atherosclerosis, during which the participants were asked to report whether a physician or health worker has informed them that they had HTN (yes/no). Additionally, baseline data consisting of two non-modifiable risk factors (sex, age) and 5 modifiable risk factors (obesity, diabetes, hypercholesterolemia, smoking, and sedentary lifestyle) were collected. Descriptive statistics involving prevalence of risk factors and multivariate logistic regression analyses to determine the strength of association between hypertension and the number of risk factors were conducted. Results: Of the 1629 study participants, about half (49.8%) had hypertension. Among hypertensive patients, 31.4% were obese and 62.3% having hypercholesterolemia. Overall, having 2 risk factors consisted the largest group of participants with HTN. After adjusting for the non-modifiable risk factors (sex, age), obesity and diabetes increased the odds of having HTN by more than two folds ([OR=2.02, CI=1.57-2.60] and [OR=2.30, CI=1.66-3.18], respectively) and hypercholesterolemia and sedentary lifestyle increased the odds for HTN by more than one fold ([OR=1.26, CI=1.02-1.56) and [OR=1.38, CI=1.12-1.70], respectively). Compared to those without HTN, having 2, 3, and 4 or 5 modifiable risk factors were significantly associated with increased odds of having HTN by about two-folds [OR=1.72, CI=1.21-2.44], two and half folds [OR=2.55, 1.74-3.74], and six folds [OR=5.96, 3.42-10.41], respectively. Conclusion: The study suggests that odds of having HTN increases with the number of modifiable risk factors for CVD. Hence, by implementing an integrated CVD program for treating and controlling modifiable risk factors of HTN would decrease the future risk of CVD and help to achieve the 2020 Impact Goal of the American Health Association.


2018 ◽  
Vol 102 ◽  
pp. S536
Author(s):  
Brittany Shelton ◽  
Deanna M. McWilliams ◽  
Paul A. MacLennan ◽  
Rhiannon D. Reed ◽  
Margaux N. Mustian ◽  
...  

2018 ◽  
Vol 30 (1) ◽  
pp. 127-135 ◽  
Author(s):  
Keith P. McCullough ◽  
Hal Morgenstern ◽  
Rajiv Saran ◽  
William H. Herman ◽  
Bruce M. Robinson

BackgroundPopulation rates of obesity, hypertension, diabetes, age, and race can be used in simulation models to develop projections of ESRD incidence and prevalence. Such projections can inform long-range planning for ESRD resources needs.MethodsWe used an open compartmental simulation model to estimate the incidence and prevalence of ESRD in the United States through 2030 on the basis of wide-ranging projections of population obesity and ESRD death rates. Population trends in age, race, hypertension, and diabetes were on the basis of data from the Centers for Disease Control and Prevention’s National Health and Nutrition Examination Survey and the US Census.ResultsThe increase in ESRD incidence rates within age and race groups has leveled off and/or declined in recent years, but our model indicates that population changes in age and race distribution, obesity and diabetes prevalence, and ESRD survival will result in a 11%–18% increase in the crude incidence rate from 2015 to 2030. This incidence trend along with reductions in ESRD mortality will increase the number of patients with ESRD by 29%–68% during the same period to between 971,000 and 1,259,000 in 2030.ConclusionsThe burden of ESRD will increase in the United States population through 2030 due to demographic, clinical, and lifestyle shifts in the population and improvements in RRT. Planning for ESRD resource allocation should allow for substantial continued growth in the population of patients with ESRD. Future interventions should be directed to preventing the progression of CKD to kidney failure.


Sign in / Sign up

Export Citation Format

Share Document